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Background
Obesity is considered the major risk factor for type 2 dia-
betes mellitus (T2DM), cardio-vascular diseases like
hypertension and atherosclerosis [1]. Catechins are the
major source of flavonols and they are comprised of var-
ious types of catechins such as epigallo catechin 3 gallate
(EGCG), epigallocatechin (EGC), epicatechin gallate
(ECG) [2]. Numbers of in vivo studies have reported
weight loss after drinking green tea for several months. To
support these in vivo findings, many in vitro studies
demonstrated effect of pure EGCG which is an important
biologically active green tea catechin in reducing triglycer-
ide accumulation in adipocytes [3]. However, these anti-
adipogenic properties of EGCG are greatly dependent on
bio-availability which is very low in animals as well as in
humans. One study showed that, peak plasma concentra-
tions in humans were 1.3 µM for EGCG after a single
dose of 1.5 mmol through oral administration [4]. Nano-
encapsulated EGCG (Nano-EGCG) may help to increase
bioavailability and to exert maximum anti-adipogenic
effects.
Materials and methods
We synthesized Nano-EGCG using sonication method.
Pure EGCG (95%) was bought from SIGMA Company.
Nano-EGCG was dissolved in phosphate buffered saline
(1XPBS) and was stored at 4 degree Celsius. 3T3-L1 Prea-
dipocytes were obtained from ATCC. Cells were cultured
using a standard protocol. Post-confluence cells were dif-
ferentiated using a standard chemical cocktail mixture.
Further cells were maintained in maturation medium and
treated with native EGCG and Nano-EGCG at 10 µM for
48 hours. Cellular triglyceride levels were measured using
an enzymatic method.
Results
Nano-EGCG significantly (p<0.05) reduced triglyceride
accumulation in mature adipocytes as compared to 1X
PBS, native EGCG and its void counterpart. EGCG
didn’t significantly reduce the cellular triglyceride accu-
mulation as compared to 1XPBS.
Conclusion
Data suggests that 10 uM of Nano-EGCG significantly
reduced triglyceride accumulation as compared to 1X
PBS, void counterpart and native EGCG.
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